logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • COVID-19
Filter

COVID-19

Categories

Sectors

Locations

Exchange

阿里巴巴发起的“全球新冠肺炎实战共享平台”

Global Medical Institutions Scramble to Join Alibaba’s Covid-19 Insight-Sharing Platform

Mar 27, 2020

Life Science, Technology

特朗普 20国集团 Covid-19 新冠病毒 TherapeuticsMD

Healthcare Roundup –Trump says G-20 nations coordinating on Covid-19, TherapeuticsMD suspends guidance due to Covid-19

Mar 27, 2020

Life Science

Mylan 辉瑞 Upjohn 新冠病毒

Mylan and Upjohn Delay Close of Merger Due to COVID-19 Pandemic

Mar 26, 2020

Life Science

联想 武汉 新冠病毒

Lenovo’s Wuhan Plant Is on Track to Regain 60% of Capacity by Month’s End

Mar 26, 2020

Technology

迈兰 克力芝 吉利德 孤儿药 瑞德昔韦

Healthcare Roundup – Mylan waives exclusive U.S. rights to generic Kaletra, Gilead to withdraw Orphan Drug tag for remdesivir

Mar 25, 2020

Life Science

Sorrento 迈博药业 新冠病毒 新冠肺炎

Sorrento Collaborates with Mabpharm on Development and Commercialization of Ace-Mab™ to Potentially Treat COVID-19

Mar 25, 2020

Life Science

吉利德瑞德昔韦将委托中国企业制造,复制瑞德昔韦属谣言

Gilead Mulls Hiring Remdesivir OEMs in China if Drug Passes Clinical Trials

Mar 25, 2020

Life Science

特朗普 恢复营业 新冠病毒

Healthcare Roundup –Trump would like country open for business by Easter Sunday, U.S. coronavirus cases near 47K

Mar 24, 2020

Life Science

软银 阿里巴巴股票 推特 指导 病毒

Technology Roundup – SoftBank selling $14B in Alibaba shares, Twitter pulls guidance as it measures virus impact

Mar 24, 2020

Technology

吉利德 瑞德昔韦 COVID-19 新冠病毒 疟疾药物

Healthcare Roundup – Gilead’s remdesivir wins orphan drug status for coronavirus, New York launches use of malaria drug to treat Covid-19

Mar 23, 2020

Life Science

协同作战,亚马逊配送新冠病毒自检包

Amazon will deliver and pick up at-home test kits provided by new coronavirus program in Seattle

Mar 23, 2020

Life Science

东京奥运会有可能推迟一年

Japan in Talks With IOC to Postpone Tokyo Olympics by One Year – Report

Mar 23, 2020

Consumer Goods, Life Science

PDAC2020 nai500_Jeffery Chirstian

Jeffrey Christian: Politics will Have More Influence on the Gold Price in 2020 – PDAC2020

Mar 23, 2020

Mining

Ovation Science (CSE OVAT)

Ovation Science Inc. Grants Stock Options

Mar 20, 2020

Mining

梯瓦制药 冠状病毒 疟疾药物,意大利 疫情

Healthcare Roundup – Teva to donate 6M doses of malaria drug for coronavirus use, Italy now world’s #1 Covid-19 hotspot

Mar 20, 2020

Life Science

新冠病毒 中国 疫苗 试验

First-Phase Clinical Trials of China’s First Covid-19 Vaccine to Last Nine Months

Mar 19, 2020

Life Science

香港 狗 新冠病毒 渔护署

Hong Kong’s Authorities were notified by the owner of the 17-year old Pomeranian that the dog had died on Monday

Mar 19, 2020

Life Science

Ovation Science (CSE OVAT)

Ovation Science Ramps-Up Its Manufacturing of DermSafe as Health Canada Takes Action to Increase the Supply of Hand Sanitizers to Manage the Spread of Coronavirus COVID-19

Mar 19, 2020

Life Science

  • ‹‹ Previous
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada